Join us in congratulating Amel Aziba on being selected as the third recipient of an EACR - @moloncology.bsky.social Editorial Fellowship! Learn more about Amel and the Fellowship: magazine.eacr.org/amel-aziba-r...

📘 We are pleased to share our new Thematic issue: European Code Against Cancer – 5th Edition #ECAC5. 🌐ECAC5 provides public health recommendations, and its effective implementation could prevent up to 40% of new cancers in the EU. 👉 Find out more here: febs.onlinelibrary.wiley.com/toc/18780261...

🎗️In support of #WorldCancerDay, Molecular Oncology invites cancer researchers to take part in a writing competition aimed at envisioning a landscape in the year 2050 where #CancerPrevention is as transformative as cancer treatment. ✍ Further details: febs.onlinelibrary.wiley.com/hub/journal/...

As we wrap up 2025, we look back with gratitude on the outstanding 12 issues we have put together this year—made possible by your support. Here's to a year of impactful science and collaboration. Wishing you a joyful holiday season 🧑‍🎄 and a prosperous New Year ahead. 💥 #HappyHolidays #HappyNewYear

🔦 Have you seen our latest Commentary? TREX1, a predator for treating MSI-H tumors? 🔓 buff.ly/MAOG3pB #cGASSTING #ImmuneEvasion #CancerResearch

Next-generation proteomics improves lung cancer risk prediction ➡️ buff.ly/HuGy5mW #Proteomics #LungCancer #CancerRisk #MassSpec

📢Call for papers 📭Submit your latest research in the field of #LiquidBiopsy ➡️Format: Research Article, Short Report or Method ➡️Details buff.ly/ATND9t1 #ACTC2025 #CTC #ctDNA #Cancer

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer 👉 buff.ly/eiXX4Km #ctDNA #BCSM #LiquidBiopsy

📣 New Commentary available A subset of MMR-proficient colon cancers responds to neoadjuvant immunotherapy 🔓 buff.ly/DD6XMCS 🖊️ @Albert0Bardelli #ctDNA #TME #ColonCancer

🛠️ New Method online! Molecular characterisation of human penile carcinoma and generation of paired epithelial primary cell lines 👉 buff.ly/plPVqud 🖊️ @Dr_Andrology #Urology #UrOnc #Wntsignaling

🤝 In conjunction with the recent @helloeacr.bsky.social conference on #CancerNeuroscience we have an active call for papers! 📩 Submit your latest Research Article, Short Report or Method in the field of #BrainTumours #CNStumours #NeuroOncology 👉 More details buff.ly/OfzaVDe

Methylation biomarkers can distinguish pleural mesothelioma from healthy pleura and other pleural pathologies 🔦 buff.ly/jhH0yQu #CancerBiomarkers #PleuralMesothelioma #DNAmethylation

New Policy article now available European Code Against Cancer, 5th edition – hormone replacement therapy, other common medical therapies and cancer 🔓 buff.ly/Ch17N9f #HormoneReplacementTherapy #HormonalContraceptive #Aspirin

Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway 👉 buff.ly/AOrrON6 #p21 #ColonCancer #Stemness #NFκB

🔍 We are looking for papers! 📩 Submit your latest research in the field of #CancerImmunology #ImmunoOnc 🖊️ Whether it is a Research Article, Short Report or Method, your paper would be suitable! 👉 Find out more details buff.ly/ZDb3rO0

Dual targeting of RET and SRC synergizes in RET fusion-positive cancer cells 🔦 buff.ly/wj2wwUX @EmilianoCocco2 #NSCLC #RETfusion #FusionProtein

Transcriptional network analysis of PTEN-protein-deficient prostate tumors reveals robust stromal reprogramming and signs of senescent paracrine communication 👉 buff.ly/3RjSDs7 🖊️ @imendizabal1 @ArkaitzLab #PTEN #PCSM #TumourMicroenvironment #TumorStroma

📑 New Review for your reading list Cis-regulatory and long noncoding RNA alterations in breast cancer – current insights, biomarker utility, and the critical need for functional validation 🔓 buff.ly/g5WeXxC @Dr_Alex_Eustace #ncRNA #BCSM #Biomarkers

Detection of circulating tumor DNA in colorectal cancer patients using a methylation-specific droplet digital PCR multiplex 🔓 buff.ly/CG0J1Ck #ctDNA #ddPCR #CRC #Epigenetics #CancerDiagnostics #Biomarkers

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107 🔦 buff.ly/hlA2obL #PARPi #BladderCancer #BRCA #

Effect of chemotherapy on passenger mutations in metastatic colorectal cancer 👉 buff.ly/WGihs9T #Chemotherapy #Metastasis #CRCSM

🚨 New Review alert - don't miss this Strength through diversity: how cancers thrive when clones cooperate 🔓 buff.ly/kQAi97p #TumourHeterogeneity #TherapyResistance #CancerResistance

🚨 New Review alert - don't miss this Strength through diversity: how cancers thrive when clones cooperate 🔓 buff.ly/kQAi97p #TumourHeterogeneity #TherapyResistance #CancerResistance

❄️ Don't miss our November Issue🌨️ 📗 Cytomegalovirus (pp71-green) in primary prostate cancer (pan-keratin red) 📑 EACR Viewpoint on clinical KRAS/RAS inhibitors & novel strategies for RAS-mutant cancers @ciccancer.bsky.social 🔓 buff.ly/NpZSen9 #NSCLC #LUAD #Hypoxia #LungCancer

📑 If you are working on the interface of hypoxia and cancer research, this may be your cup of tea! 🦮 A guide to reactive oxygen species in tumour hypoxia: measurement and therapeutic implications 🔓 buff.ly/wrD6w1r #ROS #Hypoxia #TumourMicroenvironment

Class IIa HDACs forced degradation allows resensitization of oxaliplatin-resistant FBXW7-mutated colorectal cancer ➡️ buff.ly/SZQZJaL #HDAC #Oxaliplatin #CRCSM

The IFNγ-CIITA-MHC II axis modulates melanoma cell susceptibility to NK-cell-mediated cytotoxicity 👉 buff.ly/tJzVEhb #Melanoma #MELCSM #ImmunoOnc

🚨 New EACR Viewpoint alert The rapidly growing landscape of RAS inhibitors: from selective allele blockade to broad inhibition strategies 🔓 buff.ly/05MSKU1 #RASinhibitors #TherapyResistance #CancerResearch @helloeacr.bsky.social

🗣️New meeting announced 🟨 "Cancer Metabolism"🟨 📅 It's not too late to plan ahead Submit abstracts by Jun 29 2026 ⌛️Register by Sept 7 2026 🗓️Oct 6-8 2026 🖱️https://buff.ly/s88vxNH #CancerMetabolism #Metabolism #MetabolicReprogramming #CancerResearch

Survivin and Aurora Kinase A control cell fate decisions during mitosis 👉 buff.ly/PLDmH38 #AURKA #Mitosis #CellFate

A synthetic benzoxazine dimer derivative targets c-Myc to inhibit colorectal cancer progression ➡️ buff.ly/czDTEB0 #CRCSM #CancerResearch

Aggressive prostate cancer is associated with pericyte dysfunction 👉 buff.ly/hbBYh67 🖊️ @idibell_cat @ArkaitzLab #ProstateCancer #PCSM #Pericyte

📣The joint publishing fellowship with the @EACRnews offers a remote placement at @MolOncology Get hands-on experience in scientific editing and visit the Heidelberg office ⏰Deadline Nov 7 ➡️https://buff.ly/3ZtvMe3 #PhDchat #PostDocChat #ECRchat #CancerResearch #CancerBiology

🎃 Our October issue is online👻 ❗ Read the EACR Viewpoint article by Gerlanda Vella and Maria Rescigno on the role of tumour-associated bacteria and their interplay with the tumour microenvironment in modulating cancer progression 🔓 buff.ly/xsyuvqP #Neuroendocrine #Histopathology #CancerResearch

Patient-specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity ➡️ buff.ly/OpVpLqS #Pharmacogenomics

📄 Did you know we publish EACR Viewpoints? 📣 Introduced in 2023 when Molecular Oncology became the affiliate journal of the EACR, EACR Viewpoints showcase authoritative opinions on cutting-edge topics in #CancerResearch. 🔓 You may access them here ➡️ bit.ly/4cIqPCh @FEBSnews #CancerBiology

📣 New month, new Commentary Not just a by-product: circular DNA molecules derived from V(D)J recombination are linked to worse prognosis in B-cell leukemia 🔓 buff.ly/hO4fJ9g 🖊️ @andreaventura.bsky.social #eccDNA #ecDNA

The ACCEPTance of automation: refining circulating tumor cells enumeration for improved metastatic colorectal cancer prognosis ➡️ buff.ly/XfueJAy #CTCs #mCRC #Prognosis #Oncology #CRCSM

📖 Have you leafed through our September Issue? This Issue contains recent findings on how TME changes can alter cell function and treatment outcomes. It also highlights new therapeutic opportunities based on the TME’s dynamic landscape 🔓 buff.ly/jYUuWIM #TumourMicroenvironment

Predictors of response and rational combinations for the novel MCL-1 inhibitor MIK665 in acute myeloid leukemia ➡️ buff.ly/yxF616I 🖊️ @HeckmanLab #AML #MCL1 #HemOnc

🤩 We are excited to be attending 🧠EACR Cancer Neuroscience🧠 next month 👥 Are you going? 👉 buff.ly/lTaWPhW #CancerResearch #BrainTumours #CNScancer #NeuroOncology

📣The joint publishing fellowship with the EACR @helloeacr offers a remote placement at the journal Get hands-on experience in scientific editing and visit the Heidelberg office ⏰Deadline Nov 7 ➡️https://buff.ly/3ZtvMe3 #PhDchat #PostDocChat #ECRchat #CancerResearch #CancerBiology

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism 🔦 buff.ly/SkrGsPb #Glioma #Metabolism

📣 Don't miss our new Commentary Only the strong survive: therapeutic selective pressure drives medulloblastoma leptomeningeal metastasis 🖊️ @MSKCancerCenter @adrienne_boire #Leptomeningeal #Metastasis #Medulloblastoma

📢Call for papers 📭Submit your latest research in the field of #LiquidBiopsy ➡️Format: Research Article, Short Report or Method ➡️Details buff.ly/ATND9t1 #ACTC2025 #CTC #ctDNA #Cancer

Gut microbiota diversity is prognostic in metastatic hormone receptor-positive breast cancer patients receiving chemotherapy and immunotherapy ➡️ buff.ly/8wmhhmv 🖊️ @GroupKyte #Microbiome #GutMicrobiota #BCSM #Immunotherapy

💻If you believe that curated data = quality controlled data then check out @datadryad 🤝Thanks to our partnership, authors can now enable the open sharing & reuse of their research data 👉https://buff.ly/3BkrNqd #OpenSource #OpenAccess #OpenResearch #OpenData #OpenScience

📄 Did you know we publish EACR Viewpoints? 📣 Introduced in 2023 when Molecular Oncology became the affiliate journal of the @EACRnews, EACR Viewpoints showcase authoritative opinions on cutting-edge topics in #CancerResearch 🔓 You may access them here ➡️ bit.ly/4cIqPCh @FEBSnews #CancerBiology

Tumor-agnostic detection of circulating tumor DNA in patients with advanced pancreatic cancer using targeted DNA methylation sequencing and cell-free DNA fragmentomics 🔦 buff.ly/dsaLPGJ #Fragmentomics #ctDNA #DNAmet #DNAmethylation

The influence of ROS1 fusion partners and resistance mechanisms in ROS1-TKI-treated non-small cell lung cancer patients 👉 buff.ly/X1aoIai #ROS1 #NSCLC #Oncofusions